Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma

Clinical trial NCT05868395 · RECRUITING

Trial details

NCT number: NCT05868395
Sponsor: Medical University of Vienna
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle-cell Lymphoma

Start date: 2024-01-02
Primary completion: 2027-05-24
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.